Patent Granted
26 Octubre 2010 - 1:00AM
UK Regulatory
TIDMONG
RNS Number : 9725U
Oxford Nutrascience Group PLC
26 October 2010
Oxford Nutrascience Group plc
("the Company")
Patent granted for chewy confectionery compositions
Oxford Nutrascience Group plc ("the Company") has been granted a 20 year UK
patent (from the date of submission, 7 August 2006) for its chewy confectionery
composition technology. The patent covers the Company's technology which allows
sugars to be replaced with fibres and for the product to be fortified with
vitamins and other nutraceutical ingredients.
As outlined in the Company's admission document dated 8 February 2010 the
application is listed under Patent Family 1, number 0615590.7. An application
for a European chewy confectionery patent (number 07251302.1) was submitted on
27 March 2007. The granting of the European patent is expected in due course.
The Company recently announced the launch of its CHEWYZ(TM), a reduced sugar,
high fibre, tasty, vitamin enriched soft chew. Every chew contains 50mg of Omega
3, vitamins A, C, D & E and contain 35% fibre. Chewyz will initially be launched
in Tesco Nutri Centre stores.
Marcelo Bravo, Executive Chairman and Chief Technology Officer commented,
"The granting of this patent in the UK strengthens the commercialisation of our
chews. Our Chewyz product is healthier than any other chew currently available
in the market.
"This addition to our patent portfolio provides further validation of the
Company's strategy of developing intellectual property that can be successfully
exploited to build a business in the medicine and consumer healthcare sector."
For further information:
www.oxfordnutrascience.com
Oxford Nutrascience Group Plc
Nigel Theobald, Chief Executive +44 1865 854874
Mark Way, Investor and Media Relations +44 7786 116991
ZAI Corporate Finance (Nominated Adviser)
John Depasquale +44 20 7060 2220
Sarang Shah +44 20 7060 2220
About Oxford Nutrascience Group Plc
· Oxford Nutrascience is a UK consumer healthcare company that develops
chewy confectionery, chewable tablets and liquid suspensions to allow medicines
and vitamin supplements to be taken in a more pleasant and convenient way.
· Oxford Nutrascience has developed technology for the use of soluble
fibres in medicine delivery systems that disperse and solubilise medicines,
improve taste and mouth feel, simplify processing and eliminate additives,
incorporate prebiotic health benefits.
· Chews: Oxford Nutrascience currently produces Ellactiva , a calcium chewy
supplement sold in the UK and in the Middle East, and plans to launch new chews
to complement this existing product.
· Chewable tablets and liquid suspensions: The target market for Oxford
Nutrasciences' Chewitabs(TM) and liquid suspension delivery systems are
over-the-counter ("OTC") pain relieving drugs, indigestion preparations and
cough and cold medicines.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFESFIIFSSELS
Oxford Nutrascience (LSE:ONG)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Oxford Nutrascience (LSE:ONG)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
Real-Time news about Oxford Nutra Gp (London Stock Exchange): 0 recent articles
Más de Oxford Nutra Gp Artículos de Noticias